Research Division, Greater Los Angeles VA Healthcare System, Los Angeles, California, USA.
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
BMC Mol Cell Biol. 2020 Aug 1;21(1):59. doi: 10.1186/s12860-020-00303-z.
We have previously reported 18S and 25S ribosomal RNA molecules in Candida albicans resistant to processive 5' → 3' exonuclease, appearing as cells approached stationary growth phase. Initial analysis pointed to extra phosphate(s) at their 5'- end raising the possibility that they were newly transcribed. Here we report on additional experiments exploring this possibility and try to establish which of the RNA polymerases may be transcribing them.
Oligo-ligation and primer extension again showed the presence of extra phosphate at the 5'-end of the reported processing sites for both 18S and 25S ribosomal RNA components. Inhibition of Pol I with BMH-21 increased the presence of the molecules. Quantitation with an Agilent Bioanalyzer showed that resistant 18S and 25S molecules are primarily produced in the nucleus. Utilizing an RNA cap specific antibody, a signal could be detected on these molecules via immunoblotting; such signal could be eliminated by decapping reaction. Both the cap specific antibody and eIF4E cap-binding protein, increased fold enrichment upon quantitative amplification. Antibodies specific for the RNA Polymerase II c-terminal domain and TFIIB initiator factor showed the presence of Pol II on DNA sequences for both 18S and 25S molecules in chromatin precipitation and qPCR assays. Rapamycin inhibition of TOR complex also resulted in an increase of resistant 18S and 25S molecules.
These data raise the possibility of a role for RNA Polymerase II in the production of 18S and 25S molecules and indicate that efforts for more direct proof may be worthwhile. If definitively proven it will establish an additional role for RNA Polymerase II in ribosomal production.
我们之前曾报道过对连续 5'→3'外切核酸酶具有抗性的白色念珠菌中的 18S 和 25S 核糖体 RNA 分子,这些分子出现在细胞接近静止生长阶段。最初的分析指出它们的 5'端有额外的磷酸基团,这增加了它们是新转录的可能性。在这里,我们报告了更多的实验来探索这种可能性,并试图确定哪种 RNA 聚合酶可能在转录它们。
寡聚连接和引物延伸再次显示,在报道的 18S 和 25S 核糖体 RNA 成分的加工位点的 5'端存在额外的磷酸基团。用 BMH-21 抑制 Pol I 会增加这些分子的存在。用安捷伦 Bioanalyzer 定量显示,抗性 18S 和 25S 分子主要在核内产生。利用一种 RNA 帽特异性抗体,可以通过免疫印迹在这些分子上检测到信号;脱帽反应可以消除这种信号。该抗体和 eIF4E 帽结合蛋白的定量扩增倍数增加。针对 RNA 聚合酶 II C 端结构域和 TFIIB 起始因子的特异性抗体显示,在染色质沉淀和 qPCR 分析中,Pol II 存在于 18S 和 25S 分子的 DNA 序列上。雷帕霉素抑制 TOR 复合物也导致抗性 18S 和 25S 分子的增加。
这些数据增加了 RNA 聚合酶 II 在 18S 和 25S 分子产生中的作用的可能性,并表明进行更直接的证明可能是值得的。如果这一假设被最终证明,将确立 RNA 聚合酶 II 在核糖体产生中的额外作用。